BEDMINSTER, N.J.--(BUSINESS WIRE)--Retrieve Medical (OTC: RMHI) today announced that it is entering commercial production with Retrieve Passport™, its proprietary technology platform designed to give ...

The MarketWatch News Department was not involved in the creation of this content. ATLANTA, Dec. 17, 2025 /PRNewswire/ -- Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA ...

First customer sites include the University of Arkansas for Medical Sciences, MUSC Health, and Calif.-based Acacia Clinics and Kaizen Brain Center BURLINGAME, Calif.--(BUSINESS WIRE)--Magnus Medical, ...

MORGANTOWN, W.Va., Jan. 20, 2026 /PRNewswire/ -- Omnia Medical, a medical technology company developing surgical solutions for spine and interventional pain physicians, today announced the commercial ...

The strategic alignment between Medical Affairs and Commercial functions is becoming more important than ever as pharmaceutical companies navigate increasingly complex healthcare dynamics. Effective ...

DENVER, July 23, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports treatment of the first patient in a commercial setting with QUELIMMUNE™, its U.S.

Casting actors for medical commercials and training videos. The Academy of Diagnostic & Osteopathic Medicine (ADOM) is hosting a three-week Ultrasound Simulation Lab. Participants will portray ...

Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential. On June 10, Profound Medical announced the successful completion of the first commercial benign ...

Microbot Medical is expanding its team ahead of the anticipated U.S. launch of the LIBERTY Endovascular Robotic System in Q3 2025. Microbot Medical Inc. announced the expansion of its commercial team ...

The FDA clearance follows the presentation of SANSA clinical performance data earlier this year at the SLEEP meeting. The study, drawing on data collected from 325 patients across 7 clinical sites, ...